15 completed, 2 terminated, 2 unknown, 1 recruiting. 6 Not applicable, 6 Phase 2, 4 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 5, Terminated 1 |
| Phase 2 | 6 | Completed 4, Unknown 2 |
| Phase 3 | 4 | Completed 3, Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Seborrheic Keratosis: new trials by email Literature Review of Seborrheic Keratosis trials Research Report on Seborrheic Keratosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Using an Artificial Intelligence (AI) Tool for Melanoma Diagnosis Clinical decision support tool - Malignant Melanoma of Skin, Other and Unspecified Malignant Neoplasm of Skin | Phase 3 | Recruiting | Memorial Sloan Kettering Cancer Center | 14000 | 2026-10-15 | 2026-10-22 |
| Effect of 1% Andaliman Fruit Extract Cream on Facial Seborrheic Keratosis 1% Andaliman Fruit Extract Cream - Seborrheic Keratosis | Not applicable | Completed | Universitas Sumatera Utara | 40 | 2025-01-01 | 2026-01-12 |
| A Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis SM-020 gel 1.0%, Vehicle gel - Seborrheic Keratosis | Phase 2 | Unknown | DermBiont, Inc. | 60 | 2023-11-06 | 2024-05-10 |
| Comparison of 3 in Vivo Microscopic Imaging Techniques for the Diagnosis of Pigmented Tumors Fluorescence-Advanced videodermatoscopy, Reflectance confocal microscopy, Super-high magnification dermoscopy - Basal Cell Carcinoma, Lentigo Maligna | Completed | Centre Hospitalier Universitaire de Saint Etienne | 161 | 2022-11-02 | 2024-06-24 | |
| Adaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Keratosis SM-020 - Seborrheic Keratosis | Phase 2 | Unknown | DermBiont, Inc. | 70 | 2021-10-19 | 2023-10-03 |
| Effectiveness of Sodium Fusidate Ointment Compared to Petrolatum for Wound Healing Following Cauterization Sodium Fusidate 2 % Topical Ointment, Petrolatum ointment - Seborrheic Keratosis, Acrochordon | Not applicable | Completed | Universitas Indonesia | 22 | 2021-01-01 | 2022-05-05 |
| Fast Track Diagnosis of Skin Cancer by Advanced Imaging optical coherence tomography - Malignant Melanoma, Nevus, Pigmented | Not applicable | Completed | University Hospital Bispebjerg and Frederiksberg | 41 | 2019-09-09 | 2024-06-20 |
| Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage Electrical Impedence Spectroscopy DermaSense - Melanoma (Skin), Basal Cell Carcinoma | Terminated | Aristotle University Of Thessaloniki | 50 | 2019-07-17 | 2023-07-25 | |
| Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Optimization Study Nano-Pulse Stimulation (NPS) - Lesion Skin, Seborrheic Keratosis | Not applicable | Terminated | Pulse Biosciences, Inc. | 175 | 2019-02-05 | 2023-10-30 |
| An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses A-101 Topical Solution - Seborrheic Keratosis | Phase 4 | Completed | Aclaris Therapeutics, Inc. | 41 | 2018-03-21 | 2019-10-02 |
| A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis A-101 - Seborrheic Keratosis | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 253 | 2017-05-17 | 2019-05-06 |
| Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study Nano-Pulse Stimulation (NPS) - Lesion Skin, Seborrheic Keratosis | Not applicable | Completed | Pulse Biosciences, Inc. | 58 | 2017-05-04 | 2023-08-22 |
| A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis. A-101 Solution, Vehicle Solution - Seborrheic Keratosis | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 450 | 2016-01-01 | 2018-02-06 |
| A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis A-101 Solution, Vehicle Solution - Seborrheic Keratosis | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 487 | 2016-01-01 | 2018-02-06 |
| An Open-Label Safety Study of A-101 Solution A-101 Solution - Seborrheic Keratosis | Phase 3 | Completed | Aclaris Therapeutics, Inc. | 147 | 2016-01-01 | 2018-02-07 |
| Study of A-101 for the Treatment of Seborrheic Keratosis A-101 - Seborrheic Keratosis | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 119 | 2014-10-01 | 2020-12-02 |
| Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis A-101 Vehicle, A-101 (40) Topical Solution, A-101 (32.5) Topical Solution - Seborrheic Keratosis | Phase 2 | Completed | Aclaris Therapeutics, Inc. | 172 | 2014-06-01 | 2019-01-03 |
| Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis PEP005 (ingenol mebutate) Gel - Seborrheic Keratosis | Phase 2 | Completed | Peplin | 24 | 2010-10-01 | 2011-01-25 |
| Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses? cryosurgery, Curettage - Seborrheic Keratosis | Not applicable | Completed | Milton S. Hershey Medical Center | 25 | 2010-07-01 | 2018-05-25 |
| Optical Biopsy of Human Skin in Conjunction With Laser Treatment Optical Biopsy imaging - Malignant Melanoma, Merkel Cell Carcinoma | Completed | University of California, Irvine | 113 | 1999-06-01 | 2022-10-20 |
Keratosis, Seborrheic (20) · Melanoma (5) · Carcinoma, Basal Cell (4) · Carcinoma, Squamous Cell (2) · Dysplastic Nevus Syndrome (2) · Hemangioma (2) · Hutchinson's Melanotic Freckle (2) · Nevus (2) · Nevus, Pigmented (2) · Burns (1) · Carcinoma, Merkel Cell (1) · Carcinosarcoma (1) · Histiocytoma, Benign Fibrous (1) · Keratosis, Actinic (1) · Lentigo (1)
Keratosis (20) · Skin Diseases (20) · Skin and Connective Tissue Diseases (20) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Germ Cell and Embryonal (5) · Neoplasms, Nerve Tissue (5) · Neuroectodermal Tumors (5) · Neuroendocrine Tumors (5) · Nevi and Melanomas (5) · Skin Neoplasms (5) · Carcinoma (4) · Neoplasms, Basal Cell (4) · Neoplasms, Glandular and Epithelial (4)
N-phenylacetoaminomethylene-DL-p-nitrophenylalanine (3) · 3-ingenyl angelate (1) · Cryosurgery (1) · Curettage (1) · Fusidic Acid (1) · Gels (1) · Ointments (1) · Solutions (1) · Tomography, Optical Coherence (1) · Ultrasonography, Doppler (1)
Aclaris Therapeutics, Inc. (7) · DermBiont, Inc. (2) · Pulse Biosciences, Inc. (2) · Aristotle University Of Thessaloniki (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Memorial Sloan Kettering Cancer Center (1) · Milton S. Hershey Medical Center (1) · Peplin (1) · Universitas Indonesia (1) · Universitas Sumatera Utara (1) · University Hospital Bispebjerg and Frederiksberg (1) · University of California, Irvine (1)
United States (13) · Indonesia (2) · Australia (1) · Denmark (1) · El Salvador (1) · France (1) · Greece (1)
Stuart D Shanler, MD (4) · Richard A Nuccitelli, PhD (2) · Andrew Blauvelt, MD, MBA (1) · Brian Beger, BS (1) · Daniel M Stewart, DO (1) · David C Wilson, MD (1) · David Gordon, MD (1) · David Zepeda, MD (1) · Emmanouil Papanastasiou, Dr. (1) · Firman Parrol, MD (1) · Imam Budi Putra, MD (1) · Janet Dubois, MD (1) · John S Nelson, M.D,Ph.D (1) · Jonathan S Weiss, MD (1)
R01CA293974 (1)